Overlap Syndrome

Neurology·MeSH: Nervous System Diseases

6 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
JAK Inhibitor	Assertio Holdings, Inc. (ASRT)

Phase 2(5)

Drug	Company
Busulfan	Assertio Holdings, Inc. (ASRT)
Fludarabine	Assertio Holdings, Inc. (ASRT)
Melphalan	Assertio Holdings, Inc. (ASRT)
Tacrolimus	Assertio Holdings, Inc. (ASRT)
Tacrolimus	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 6 drugs in development for Overlap Syndrome across 2 companies.

There are 1 clinical trial targeting Overlap Syndrome tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.